Marshall Wace, LLP Ironwood Pharmaceuticals Inc Transaction History

Marshall Wace, LLP

  • $81.7 Billion
  • Q2 2025

A detailed history of Marshall Wace, LLP transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Marshall Wace, LLP holds 3,993,557 shares of IRWD stock, worth $7.67 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,993,557
Previous 557,521 616.31%
Holding current value
$7.67 Million
Previous $819,000 251.04%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
BUY
$0.57 - $1.44 $1.96 Million - $4.95 Million
3,436,036 Added 616.31%
3,993,557 $2.88 Million
Q1 2025

May 15, 2025
BUY
$1.41 - $4.58 $786,104 - $2.55 Million
557,521 New
557,521 $819,000
Q2 2024

Aug 14, 2024
SELL
$5.58 - $8.61 $1.98 Million - $3.06 Million
-355,282 Reduced 62.06%
217,218 $1.42 Million
Q1 2024

May 15, 2024
BUY
$8.32 - $15.45 $2.37 Million - $4.4 Million
284,680 Added 98.91%
572,500 $4.99 Million
Q4 2023

Feb 14, 2024
BUY
$8.79 - $11.51 $1.23 Million - $1.61 Million
140,075 Added 94.81%
287,820 $3.29 Million
Q3 2023

Nov 14, 2023
BUY
$8.25 - $11.35 $1.22 Million - $1.68 Million
147,745 New
147,745 $1.42 Million
Q2 2021

Aug 13, 2021
BUY
$10.16 - $13.11 $4.12 Million - $5.32 Million
405,520 Added 3037.6%
418,870 $5.39 Million
Q1 2021

May 17, 2021
BUY
$9.04 - $11.86 $120,683 - $158,331
13,350 New
13,350 $149,000
Q4 2020

Feb 16, 2021
SELL
$9.05 - $12.2 $1.58 Million - $2.12 Million
-174,084 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$8.99 - $10.74 $552,345 - $659,865
61,440 Added 54.54%
174,084 $1.57 Million
Q2 2020

Aug 13, 2020
SELL
$9.14 - $11.97 $508,659 - $666,154
-55,652 Reduced 33.07%
112,644 $1.16 Million
Q1 2020

May 15, 2020
SELL
$8.58 - $14.01 $7.86 Million - $12.8 Million
-915,880 Reduced 84.48%
168,296 $1.7 Million
Q4 2019

Feb 14, 2020
SELL
$8.22 - $14.0 $154,988 - $263,970
-18,855 Reduced 1.71%
1,084,176 $14.4 Million
Q3 2019

Nov 14, 2019
BUY
$8.59 - $10.96 $8.8 Million - $11.2 Million
1,024,762 Added 1309.28%
1,103,031 $9.48 Million
Q2 2019

Aug 14, 2019
SELL
$9.8 - $12.89 $445,713 - $586,250
-45,481 Reduced 36.75%
78,269 $856,000
Q1 2019

May 14, 2019
BUY
$8.27 - $12.73 $1.02 Million - $1.58 Million
123,750 New
123,750 $1.67 Million

Others Institutions Holding IRWD

# of Institutions
181
Shares Held
159M
Call Options Held
11.2M
Put Options Held
0
View Full List

About IRONWOOD PHARMACEUTICALS INC

IRWD Quotes by TradingView
  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $294M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email